COMPANY PROFILE

Amphix Bio

Explore full profile

Provides bio-inspired materials for regenerative medicine

Chicago, United StatesFounded 2019Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2019
Headquarters: Chicago, United States
Employees: 9
Open positions: None listed
Dealroom signal: 86.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Dec 2025	$0	—	Undisclosed	↗
SEED✓Equity / VC	Dec 2025	$13M	$50M	Undisclosed	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Amphix Bio website traffic

Latest recorded traffic for Amphix Bio is 2.1K monthly website visits, up 31.3% over the last three months. Amphix Bio's team grew 80% over the past year.

Latest monthly visits2.1K 3-month web change+31.3% 1-year team growth+80%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ZBZhuhai Medefa BiotechnologyInnovative biodegradable PHA materials for medical devices and eco-friendly applications	China	Operational	—	$2.8M	$11M
RBRealmind BiotechFocuses on the R&D, production and sales of POCT real-time detection innovation platforms and specialty reagent projects	Nanjing City, China	Operational
SBSpear BioOffers opportunities for better detections with less invasive biospecimen collection	Woburn, United States	Operational
HAHaiiDeveloping innovative digital therapeutics in the prevention and management of mental health and disease such as dementia, depression, and anxiety disorders	Seoul, South Korea	Operational
SYSyantraPrecision healthcare company that focuses on the commercialization of breast cancer detection blood tests	Calgary, Canada	Operational
HEHemoraiEnables clinicians to extend acute care to the patient’s home via reliable continuous monitoring of Hemodynamics	Austin, United States	Operational
KTKeapstone TherapeuticsSmall molecule activators for neurodegenerative disease therapies	Sheffield, United Kingdom	Operational
RERe-VanaTo advance the quality of care for patients suffering from sight-threatening diseases.	Belfast, United Kingdom	Operational